These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 10631762

  • 1. Effect of CCK-4 on a 35% carbon dioxide challenge in healthy volunteers.
    Pols H, Griez E, Bourin M, Schruers K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Nov; 23(8):1345-50. PubMed ID: 10631762
    [Abstract] [Full Text] [Related]

  • 2. 10 microg CCK-4 premedication and 35% CO2 challenge in healthy volunteers.
    Schruers K, Pols H, Overbeek T, Griez E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Apr; 24(3):409-18. PubMed ID: 10836489
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteers.
    Tõru I, Maron E, Raag M, Vasar V, Nutt DJ, Shlik J.
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):645-52. PubMed ID: 22939006
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers.
    Shlik J, Vasar V, Aluoja A, Kingisepp PH, Jagomägi K, Vasar E, Rägo L, Bradwejn J.
    Biol Psychiatry; 1997 Aug 01; 42(3):206-12. PubMed ID: 9232213
    [Abstract] [Full Text] [Related]

  • 8. Effect of aging on cholecystokinin-induced panic.
    Flint AJ, Koszycki D, Vaccarino FJ, Cadieux A, Boulenger JP, Bradwejn J.
    Am J Psychiatry; 1998 Feb 01; 155(2):283-5. PubMed ID: 9464213
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dose ranging study of the effects of cholecystokinin in healthy volunteers.
    Bradwejn J, Koszycki D, Bourin M.
    J Psychiatry Neurosci; 1991 Jul 01; 16(2):91-5. PubMed ID: 1911739
    [Abstract] [Full Text] [Related]

  • 12. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder.
    Bradwejn J, Koszycki D, Annable L, Couëtoux du Tertre A, Reines S, Karkanias C.
    Biol Psychiatry; 1992 Nov 15; 32(10):903-12. PubMed ID: 1467375
    [Abstract] [Full Text] [Related]

  • 13. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder.
    Bradwejn J, Koszycki D, Couëtoux du Tertre A, van Megen H, den Boer J, Westenberg H.
    Arch Gen Psychiatry; 1994 Jun 15; 51(6):486-93. PubMed ID: 8192551
    [Abstract] [Full Text] [Related]

  • 14. Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers.
    Aluoja A, Shlik J, Vasar V, Kingisepp PH, Jagomägi K, Vasar E, Bradwejn J.
    Psychiatry Res; 1997 Jan 15; 66(1):59-67. PubMed ID: 9061804
    [Abstract] [Full Text] [Related]

  • 15. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    World J Biol Psychiatry; 2012 Oct 15; 13(7):526-34. PubMed ID: 22111662
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorder.
    Bradwejn J, Koszycki D.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Oct 15; 15(2):237-9. PubMed ID: 1908105
    [Abstract] [Full Text] [Related]

  • 17. The 35% CO2 challenge test in patients with social phobia.
    Caldirola D, Perna G, Arancio C, Bertani A, Bellodi L.
    Psychiatry Res; 1997 Jun 16; 71(1):41-8. PubMed ID: 9247980
    [Abstract] [Full Text] [Related]

  • 18. Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks.
    Nardi AE, Valença AM, Nascimento I, Mezzasalma MA, Zin WA.
    Psychiatry Res; 2000 May 15; 94(2):179-84. PubMed ID: 10808043
    [Abstract] [Full Text] [Related]

  • 19. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
    Kellner M, Wiedemann K, Yassouridis A, Levengood R, Guo LS, Holsboer F, Yehuda R.
    Biol Psychiatry; 2000 Jan 15; 47(2):107-11. PubMed ID: 10664826
    [Abstract] [Full Text] [Related]

  • 20. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Jan 15; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.